Norway was criticized by the EU Medicines Agency due to its AstraZeneca vaccine position: “A lot of resistance” 

AstraZeneca vaccinesPhoto: Ole Berg-Rusten / NTB
Advertisements

After Norway stopped using the AstraZeneca vaccine last year and said it could lead to blood clots, the EU Medicines Agency (EMA) called Norwegian representatives in for a meeting.

“Internationally, we met a lot of resistance. We were called on the carpet by the EMA, i.e., the EU Medicines Agency,” Norwegian Medicines Agency chief physician Sigurd Hortemo told the newspaper VG.

On March 11 last year, Norway stopped using the AstraZeneca vaccine after five people died of blood clots, low platelets, and bleeding after taking the vaccine.

One week later, doctors at Rikshospitalet concluded that it was the vaccine that led to these rare blood clots in otherwise completely healthy people. The EMA was not satisfied with Norway’s actions.

“They thought we went out too early with too bad a basis and were afraid of the (impact on the) reputation of the vaccination,” Hortemo told the newspaper.

The EMA first concluded that the blood clots could not be linked to the vaccine but later reversed its position.

Source: © NTB Scanpix / #Norway Today / #NorwayTodayNews

Do you have a news tip for Norway Today? We want to hear it. Get in touch at info@norwaytoday.no

Advertisements

1 Comment on "Norway was criticized by the EU Medicines Agency due to its AstraZeneca vaccine position: “A lot of resistance” "

  1. This is the kind of thing that led to Britain’s exit from the EU.

    Why not (instead) use vaccines that don’t kill *anyone*?

    GOOD call, Norway!

Leave a comment

Your email address will not be published.


*